Cardiology Department, Villa Bianca Hospital Trento, Italy.
Int J Cardiol. 2013 Oct 9;168(4):3691-7. doi: 10.1016/j.ijcard.2013.06.020. Epub 2013 Jul 11.
Chronic renal dysfunction (RD) frequently coexists with heart failure (HF) and influences outcome. Patients with acute HF (AHF) and severe RD are frequently excluded in the trials. We characterized these subjects and assessed incidence and predictors of in-hospital and one-year mortalities.
We selected the 455 patients included in the "IN-HF Outcome" Italian registry belonging to the lowest quartile of estimated glomerular filtration rate (eGFR<40 ml/min/1.73 m(2)).
Mean eGFR at entry in severe RD patients was 28±9 ml/min/1.73 m(2). Compared to 1368 patients with more preserved eGFR, they were older, with more co-morbidities and more frequently ischemic etiology of HF. In-hospital and one-year all-cause mortality rates were 14% and 44% respectively, twice higher than the entire population. Predictors of in-hospital mortality were an abnormal status of consciousness, older age, hyponatremia, lower systolic blood pressure and eGFR. The same conditions (except eGFR) predicted one-year mortality together with the absence of diabetes and no treatment with beta-blockers or diuretics.
In patients with AHF and severe RD, in-hospital and one-year all-cause mortality rates are very high. Independent predictors such as older age, and signs of hypoperfusion and hyponatremia may be identified but preventing and reversing RD remain the key targets for the clinical management of these patients.
慢性肾功能不全(RD)常与心力衰竭(HF)并存,并影响预后。急性心力衰竭(AHF)和严重 RD 的患者经常被排除在试验之外。我们对这些患者进行了特征描述,并评估了住院期间和一年死亡率的发生率和预测因素。
我们选择了“IN-HF 结局”意大利注册研究中属于估计肾小球滤过率(eGFR<40ml/min/1.73m(2))最低四分位数的 455 名患者。
严重 RD 患者的 eGFR 初始值为 28±9ml/min/1.73m(2)。与 eGFR 保存较好的 1368 名患者相比,这些患者年龄较大,合并症较多,心力衰竭的缺血性病因更为常见。住院期间和一年的全因死亡率分别为 14%和 44%,是整个人群的两倍。住院死亡率的预测因素是意识状态异常、年龄较大、低钠血症、较低的收缩压和 eGFR。相同的条件(除了 eGFR)预测了一年死亡率,同时还预测了没有糖尿病以及没有使用β受体阻滞剂或利尿剂治疗。
在 AHF 和严重 RD 患者中,住院期间和一年的全因死亡率非常高。可以识别出一些独立的预测因素,如年龄较大,以及低灌注和低钠血症的迹象,但预防和逆转 RD 仍然是这些患者临床管理的关键目标。